Back
Results - Announcements
Sales decline 1.02% to Rs 72.54 crore
Balaxi Pharmaceuticals consolidated net profit declines 94.22% in the December 2025 quarter
02-Feb-2026, 06:11
Net profit of Balaxi Pharmaceuticals declined 94.22% to Rs 0.31 crore in the quarter ended December 2025 as against Rs 5.36 crore during the previous quarter ended December 2024. Sales declined 1.02% to Rs 72.54 crore in the quarter ended December 2025 as against Rs 73.29 crore during the previous quarter ended December 2024.
Net profit of Balaxi Pharmaceuticals declined 94.22% to Rs 0.31 crore in the quarter ended December 2025 as against Rs 5.36 crore during the previous quarter ended December 2024. Sales declined 1.02% to Rs 72.54 crore in the quarter ended December 2025 as against Rs 73.29 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended | ||
| Dec. 2025 | Dec. 2024 | % Var. | |
| Sales | 72.54 | 73.29 | -1 |
| OPM % | 4.26 | 5.44 | - |
| PBDT | 2.17 | 6.55 | -67 |
| PBT | 1.61 | 6.07 | -73 |
| NP | 0.31 | 5.36 | -94 |
Powered by Capital Market - Live News